Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Noked Israel Ltd

Q3 2024 · 13F-HR

Noked Israel Ltdholdings as filed

Filed 2024-11-14 · accession 0001178913-24-003690

$457,715
Reported value
18
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
874039100TSMTAIWAN SEMICONDUCTOR MFG LTD$80,37417.6%462,800CommonSOLE
594918104MSFTMICROSOFT CORP$72,29015.8%168,000CommonSOLE
M7S64H106MNDYMONDAY COM LTD$53,37411.7%192,150CommonSOLE
M98068105WIXWIX COM LTD$52,52811.5%314,220CommonSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$51,67011.3%2,867,353CommonSOLE
30303M102METAMETA PLATFORMS INC$31,0556.78%54,250CommonSOLE
09857L108BKNGBOOKING HOLDINGS INC$18,9554.14%4,500CommonSOLE
M7516K103NVMINOVA LTD$18,7094.09%89,800CommonSOLE
02079K107GOOGALPHABET INC$18,3914.02%110,000CommonSOLE
037833100AAPLAPPLE INC$12,9052.82%55,450CommonSOLE
M20791105CAMTCAMTEK LTD$11,9142.60%149,200CommonSOLE
G3643J108FLUTFLUTTER ENTMT PLC$11,8642.59%50,000CommonSOLE
79466L302CRMSALESFORCE INC$10,9482.39%40,000CommonSOLE
M5216V106GLBEGLOBAL E ONLINE LTD$5,7661.26%150,000CommonSOLE
46090E103QQQINVESCO QQQ TR$3,3870.74%6,940CommonSOLE
78462F103SPYSPDR S&P 500 ETF TR$2,7510.60%4,794CommonSOLE
98386D307XTL BIOPHARMACEUTICALS LTD$4770.10%198,888CommonSOLE
M20791905CAMTEK LTD$3570.08%300CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.